GlassScriptPhysician profile
Faiz U Rehman
NPI 1730168261
$4,267.49
in general payments reported to CMS, 2019-2025
36 companies · $856 in 2025
The $856 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $327 · 2021: $303 · 2022: $764 · 2023: $746 · 2024: $678 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,279.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $533.05 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $476.97 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $429.54 | 2019-2025 | Jardiance |
| Amgen INC. | $353.96 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $350.88 | 2023-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $211.36 | 2019-2024 | Farxiga, Wainua, Andexxa |
| Janssen Pharmaceuticals, INC | $202.06 | 2019-2024 | Xarelto |
| Abbott Laboratories | $198.29 | 2022-2025 | Cardiomems, Mitraclip |
| Pfizer INC. | $189.05 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.68 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $179.91 | 2020-2025 | Avvigo Guidance System, Emblem Mri S-Icd, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $152.10 | 2021-2024 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $80.66 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $76.07 | 2019 | |
| Philips North America LLC | $65.81 | 2022-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $63.37 | 2019-2020 | |
| Cvrx, INC. | $53.65 | 2023-2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $52.41 | 2024 | Arcalyst |
| Medtronic, INC. | $47.39 | 2023-2025 | Aurora Ev-Icd Mri Surescan, Micra |
| Edwards Lifesciences Corporation | $37.02 | 2022 | |
| Vital Connect, INC | $31.82 | 2023-2024 | Vitalpatch Rtm |
| Cardiva Medical, INC. | $31.68 | 2022 | |
| Ionis Pharmaceuticals, INC. | $31.15 | 2025 | Tryngolza |
| Esperion Therapeutics, INC. | $29.18 | 2020-2025 | Nexletol |
| Atricure, INC. | $23.92 | 2022 | |
| Irhythm Technologies, INC. | $23.36 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $23.21 | 2019 | |
| Glaxosmithkline, LLC. | $18.66 | 2025 | Arexvy, Shingrix |
| Aegerion Pharmaceuticals, INC. | $18.00 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $17.22 | 2023 | Inpefa |
| Terumo Medical Corporation | $16.77 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $15.08 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.03 | 2019 | |
| Amarin Pharma, INC. | $13.84 | 2019 | |
| Allergan, INC. | $12.34 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faiz Rehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.